Dynavax Technologies Corporation (DVAX)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.65 | 1.56 | 1.58 | 1.60 | 1.60 | 1.61 | 1.62 | 1.72 | 1.70 | 2.00 | 2.42 | 3.51 | 4.67 | 13.61 | 7.77 | 4.91 | 6.02 | 5.10 | 5.65 | 21.93 |
Dynavax Technologies Corporation has consistently maintained a strong solvency position as evidenced by its low debt-to-assets, debt-to-capital, and debt-to-equity ratios, which have all remained at 0.00 throughout the reported periods. This indicates that the company has minimal debt relative to its assets, capital, and equity, highlighting a low financial risk and a healthy financial structure.
Furthermore, the financial leverage ratio, which measures the extent to which the company relies on debt in its capital structure, has shown a declining trend from 21.93 in March 2020 to 1.65 in December 2024. This decreasing trend indicates that the company has been reducing its financial leverage over the years, demonstrating an improving ability to meet its financial obligations and an increased stability in its financial position.
Overall, Dynavax Technologies Corporation's solvency ratios reflect a strong financial footing, with minimal debt levels and decreasing reliance on leverage, suggesting a healthy and sustainable financial position for the company.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 4.22 | 2.59 | 3.60 | 2.08 | 0.33 | 10.72 | 18.46 | 36.28 | 44.72 | 49.60 | 35.89 | 14.44 | 7.94 | -1.69 | 0.67 | -2.24 | -2.95 | -4.05 | -6.03 | -5.62 |
The interest coverage ratio for Dynavax Technologies Corporation has displayed significant fluctuations over the observed periods.
Between March 31, 2020, and June 30, 2021, the interest coverage ratio remained negative, indicating that the company's earnings were insufficient to cover its interest expenses during these periods.
From December 31, 2021, onwards, the interest coverage ratio turned positive, suggesting an improvement in the company's ability to meet its interest obligations from its operating earnings.
The trend continued to strengthen through December 31, 2024, where the interest coverage ratio reached 4.22, indicating that Dynavax Technologies Corporation's operating income was 4.22 times greater than its interest expenses during that period.
Overall, the improving interest coverage ratio reflects a positive trajectory for the company's financial health and ability to manage its debt obligations.